Sprifermin is another name for human recombinant FGF18. Its manufacturers hope it will soon enter clinical trials for treatment of knee osteoarthritis.
References
Sprifermin Wikipedia(Text) CC BY-SA
Sprifermin
Updated on
Edit
Like
Comment
Similar Topics